← Back to guidelines
Ophthalmology24 papers

Paraneoplastic encephalomyelitis

Last edited: 4/15/2026

Overview

Paraneoplastic encephalomyelitis refers to a group of neurological disorders associated with malignancies, characterized by autoimmune responses often mediated by autoantibodies due to molecular mimicry between tumor antigens and self-antigens 12. These syndromes can affect both afferent and efferent visual pathways, often preceding the diagnosis of underlying cancer 13.

Diagnosis

  • Clinical presentation with systemic malignancy and neurological symptoms
  • Presence of specific autoantibodies (e.g., anti-Hu, anti-Yo, anti-Ri) can aid diagnosis but is not definitive 12
  • Neuro-ophthalmologic evaluations including visual acuity, pupillary reflexes, and eye movement assessments 3
  • Imaging studies (MRI, CT) to rule out local tumor invasion 1
  • Management

  • Treatment primarily targets the underlying malignancy 1
  • Immunosuppressive therapy (e.g., corticosteroids, intravenous immunoglobulin) for managing autoimmune manifestations 1
  • Specific symptomatic treatments:
  • - Myasthenia Gravis: acetylcholinesterase inhibitors (e.g., pyridostigmine) 1 - Lambert-Eaton Myasthenic Syndrome: 3,4-diaminopyridine 1
  • Supportive care for neurological deficits 1
  • Special Populations

  • Pediatrics: Neurological syndromes can occur with neuroblastoma 1
  • Elderly: Increased complexity in diagnosis due to comorbidities; careful evaluation essential 1
  • Comorbidities: Presence of other autoimmune conditions may complicate management 1
  • Key Recommendations

  • Consider paraneoplastic encephalomyelitis in patients with unexplained neurological symptoms and a history of malignancy (Evidence: Moderate 13)
  • Utilize autoantibody testing to support diagnosis but recognize its limitations (Evidence: Moderate 12)
  • Aggressive management of underlying cancer is crucial for potential neurological improvement (Evidence: Expert opinion 1)
  • References

    1 Parrado-Carrillo A, Alcubierre R, Camós-Carreras A, Sanchez-Dalmau BF. Paraneoplastic syndromes in ophthalmology. Archivos de la Sociedad Espanola de Oftalmologia 2022. link 2 Bussat A, Langner-Lemercier S, Salmon A, Mouriaux F. Paraneoplastic syndromes in ophthalmology. Journal francais d'ophtalmologie 2018. link 3 Gordon LK. Paraneoplastic Syndromes in Neuro-Ophthalmology. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2015. link

    Original source

    1. [1]
      Paraneoplastic syndromes in ophthalmology.Parrado-Carrillo A, Alcubierre R, Camós-Carreras A, Sanchez-Dalmau BF Archivos de la Sociedad Espanola de Oftalmologia (2022)
    2. [2]
      Paraneoplastic syndromes in ophthalmology.Bussat A, Langner-Lemercier S, Salmon A, Mouriaux F Journal francais d'ophtalmologie (2018)
    3. [3]
      Paraneoplastic Syndromes in Neuro-Ophthalmology.Gordon LK Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society (2015)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG